• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

DDX10 通过 U3 小核仁核糖核蛋白 IMP4 促进人肺癌增殖。

DDX10 promotes human lung carcinoma proliferation by U3 small nucleolar ribonucleoprotein IMP4.

机构信息

Department of Thoracic Surgery, Beijing Friendship Hospital, Capital Medical University, Beijing, China.

出版信息

Thorac Cancer. 2021 Jun;12(12):1873-1880. doi: 10.1111/1759-7714.13976. Epub 2021 May 11.

DOI:10.1111/1759-7714.13976
PMID:33973712
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8201537/
Abstract

BACKGROUND

Lung cancer is a common tumor and a leading cause of death worldwide. DEAD/H box RNA helicases (DDX) include several family members which regulate mRNA translation in cancer cells. In this study, we demonstrated that DEAD/H box RNA helicase 10 (DDX10) was significantly upregulated in lung cancer tissues compared with adjacent nontumor tissues.

METHODS

DDX10 expression was knocked down with shRNA in order to investigate the impact on A549 lung cancer cell growth and related molecular mechanisms in vitro and in vivo. DDX10 expression in lung cancer was assessed using online databases and patient samples.

RESULTS

DDX10 knockdown significantly inhibited the proliferation of lung cancer cells in vitro and in vivo. Furthermore, the bioinformatic tool indicated the putative downstream protein U3 small nucleolar ribonucleoprotein 4 (IMP4). Our data showed a positive correlation between IMP4 and DDX10. We found that IMP4 overexpression could reverse the effect of DDX10 knockdown on the proliferation and apoptosis of A549 cells.

CONCLUSIONS

The findings of this study suggest that DDX10/IMP4 might be a novel target for lung cancer diagnosis and treatment.

摘要

背景

肺癌是一种常见的肿瘤,也是全球范围内导致死亡的主要原因。DEAD/H 盒 RNA 解旋酶(DDX)包括几个家族成员,它们在癌细胞中调节 mRNA 翻译。在这项研究中,我们证明与相邻非肿瘤组织相比,肺癌组织中 DEAD/H 盒 RNA 解旋酶 10(DDX10)的表达显著上调。

方法

利用 shRNA 敲低 DDX10,以研究其对体外和体内 A549 肺癌细胞生长的影响及相关分子机制。使用在线数据库和患者样本评估肺癌中 DDX10 的表达。

结果

DDX10 敲低显著抑制了肺癌细胞在体外和体内的增殖。此外,生物信息学工具预测了下游蛋白 U3 小核仁核糖核蛋白 4(IMP4)。我们的数据显示 IMP4 与 DDX10 之间存在正相关。我们发现,IMP4 过表达可以逆转 DDX10 敲低对 A549 细胞增殖和凋亡的影响。

结论

本研究结果表明,DDX10/IMP4 可能成为肺癌诊断和治疗的新靶点。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e64c/8201537/5ce14a3d4b07/TCA-12-1873-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e64c/8201537/ec53e26b8c93/TCA-12-1873-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e64c/8201537/5ce14a3d4b07/TCA-12-1873-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e64c/8201537/ec53e26b8c93/TCA-12-1873-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e64c/8201537/5ce14a3d4b07/TCA-12-1873-g003.jpg

相似文献

1
DDX10 promotes human lung carcinoma proliferation by U3 small nucleolar ribonucleoprotein IMP4.DDX10 通过 U3 小核仁核糖核蛋白 IMP4 促进人肺癌增殖。
Thorac Cancer. 2021 Jun;12(12):1873-1880. doi: 10.1111/1759-7714.13976. Epub 2021 May 11.
2
Epigenetic down-regulated DDX10 promotes cell proliferation through Akt/NF-κB pathway in ovarian cancer.表观遗传下调的DDX10通过Akt/NF-κB通路促进卵巢癌细胞增殖。
Biochem Biophys Res Commun. 2016 Jan 22;469(4):1000-5. doi: 10.1016/j.bbrc.2015.12.069. Epub 2015 Dec 20.
3
ATG10-dependent autophagy is required for DDX10 to regulate cell proliferation, apoptosis and stemness in colorectal cancer.DDX10 通过 ATG10 依赖性自噬调控结直肠癌细胞增殖、凋亡和干性。
J Cancer Res Clin Oncol. 2024 Aug 7;150(8):386. doi: 10.1007/s00432-024-05910-3.
4
Effects of the NUP98-DDX10 oncogene on primary human CD34+ cells: role of a conserved helicase motif.NUP98-DDX10 癌基因对原代人 CD34+ 细胞的影响:保守解旋酶基序的作用。
Leukemia. 2010 May;24(5):1001-11. doi: 10.1038/leu.2010.42. Epub 2010 Mar 25.
5
[DDX10 promotes AIM2-inflammasome activation by maintaining AIM2 protein stability].DDX10通过维持AIM2蛋白稳定性促进AIM2炎性小体激活
Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi. 2020 Apr;36(4):289-296.
6
DDX10 promotes the proliferation and metastasis of colorectal cancer cells via splicing RPL35.DDX10通过剪接RPL35促进结肠癌细胞的增殖和转移。
Cancer Cell Int. 2022 Feb 2;22(1):58. doi: 10.1186/s12935-022-02478-1.
7
DDX10 overexpression predicts worse prognosis in osteosarcoma and its deletion prohibits cell activities modulated by MAPK pathway.DDX10 过表达预示着骨肉瘤预后不良,其缺失可抑制 MAPK 通路调节的细胞活性。
Biochem Biophys Res Commun. 2019 Mar 19;510(4):525-529. doi: 10.1016/j.bbrc.2019.01.114. Epub 2019 Feb 6.
8
DDX5 promotes proliferation and tumorigenesis of non-small-cell lung cancer cells by activating β-catenin signaling pathway.DDX5通过激活β-连环蛋白信号通路促进非小细胞肺癌细胞的增殖和肿瘤发生。
Cancer Sci. 2015 Oct;106(10):1303-12. doi: 10.1111/cas.12755. Epub 2015 Sep 3.
9
IMP4 Silencing Inhibits the Malignancy of Lung Adenocarcinoma via ERK Pathway.IMP4基因沉默通过ERK通路抑制肺腺癌的恶性程度。
J Oncol. 2022 Oct 22;2022:8545441. doi: 10.1155/2022/8545441. eCollection 2022.
10
Dhr1p, a putative DEAH-box RNA helicase, is associated with the box C+D snoRNP U3.Dhr1p是一种假定的DEAH盒RNA解旋酶,与盒C+D小核仁核糖核蛋白U3相关。
Mol Cell Biol. 2000 Oct;20(19):7238-46. doi: 10.1128/MCB.20.19.7238-7246.2000.

引用本文的文献

1
DDX10 Exacerbates Exosomal PD-L1-Dependent T Cell Exhaustion via Phase Separation of Rab27b in Oral Squamous Cell Carcinoma.DDX10通过口腔鳞状细胞癌中Rab27b的相分离加剧外泌体PD-L1依赖性T细胞耗竭。
Research (Wash D C). 2025 May 9;8:0697. doi: 10.34133/research.0697. eCollection 2025.
2
Antisense oligonucleotide-mediated TRA2β poison exon inclusion induces the expression of a lncRNA with anti-tumor effects.反义寡核苷酸介导的TRA2β毒性外显子包含诱导具有抗肿瘤作用的长链非编码RNA的表达。
Nat Commun. 2025 Feb 15;16(1):1670. doi: 10.1038/s41467-025-56913-8.
3
DEAD-box RNA helicase 10 is required for 18S rRNA maturation by controlling the release of U3 snoRNA from pre-rRNA in embryonic stem cells.

本文引用的文献

1
Neoadjuvant chemotherapy and nivolumab in resectable non-small-cell lung cancer (NADIM): an open-label, multicentre, single-arm, phase 2 trial.可切除非小细胞肺癌新辅助化疗联合纳武利尤单抗(NADIM):一项开放标签、多中心、单臂、Ⅱ期临床试验。
Lancet Oncol. 2020 Nov;21(11):1413-1422. doi: 10.1016/S1470-2045(20)30453-8. Epub 2020 Sep 24.
2
GEPIA2: an enhanced web server for large-scale expression profiling and interactive analysis.GEPIA2:一个用于大规模表达谱分析和交互式分析的增强型网络服务器。
Nucleic Acids Res. 2019 Jul 2;47(W1):W556-W560. doi: 10.1093/nar/gkz430.
3
DDX10 overexpression predicts worse prognosis in osteosarcoma and its deletion prohibits cell activities modulated by MAPK pathway.
无 60 框 RNA 解旋酶 10 通过控制 U3 snoRNA 从胚胎干细胞 pre-rRNA 中的释放来控制 18S rRNA 的成熟。
Nat Commun. 2024 Nov 27;15(1):10303. doi: 10.1038/s41467-024-53822-0.
4
ATG10-dependent autophagy is required for DDX10 to regulate cell proliferation, apoptosis and stemness in colorectal cancer.DDX10 通过 ATG10 依赖性自噬调控结直肠癌细胞增殖、凋亡和干性。
J Cancer Res Clin Oncol. 2024 Aug 7;150(8):386. doi: 10.1007/s00432-024-05910-3.
5
DDX19A promotes gastric cancer cell proliferation and migration by activating the PI3K/AKT pathway.DDX19A通过激活PI3K/AKT信号通路促进胃癌细胞的增殖和迁移。
Cancer Cell Int. 2024 Aug 3;24(1):272. doi: 10.1186/s12935-024-03448-5.
6
DDX21 functions as a potential novel oncopromoter in pancreatic ductal adenocarcinoma: a comprehensive analysis of the DExD box family.DDX21在胰腺导管腺癌中作为一种潜在的新型癌基因促进因子发挥作用:对解旋酶DExD盒家族的综合分析
Discov Oncol. 2024 Aug 3;15(1):333. doi: 10.1007/s12672-024-01204-9.
7
DEAD-box RNA helicases with special reference to p68: Unwinding their biology, versatility, and therapeutic opportunity in cancer.与p68特别相关的DEAD盒RNA解旋酶:揭示其生物学特性、多功能性及在癌症治疗中的机遇
Genes Dis. 2022 Mar 21;10(4):1220-1241. doi: 10.1016/j.gendis.2022.02.008. eCollection 2023 Jul.
8
Construction of cuproptosis-related gene signature to predict the prognosis and immunotherapy efficacy of patients with bladder cancer through bioinformatics analysis and experimental validation.通过生物信息学分析和实验验证构建铜死亡相关基因特征以预测膀胱癌患者的预后和免疫治疗疗效
Front Genet. 2022 Nov 23;13:1074981. doi: 10.3389/fgene.2022.1074981. eCollection 2022.
9
IMP4 Silencing Inhibits the Malignancy of Lung Adenocarcinoma via ERK Pathway.IMP4基因沉默通过ERK通路抑制肺腺癌的恶性程度。
J Oncol. 2022 Oct 22;2022:8545441. doi: 10.1155/2022/8545441. eCollection 2022.
DDX10 过表达预示着骨肉瘤预后不良,其缺失可抑制 MAPK 通路调节的细胞活性。
Biochem Biophys Res Commun. 2019 Mar 19;510(4):525-529. doi: 10.1016/j.bbrc.2019.01.114. Epub 2019 Feb 6.
4
The human RNA helicase DHX37 is required for release of the U3 snoRNP from pre-ribosomal particles.人类 RNA 解旋酶 DHX37 对于 U3 snoRNP 从核前体颗粒中的释放是必需的。
RNA Biol. 2019 Jan;16(1):54-68. doi: 10.1080/15476286.2018.1556149. Epub 2018 Dec 27.
5
Multiple primary lung cancer: A literature review.多发性原发性肺癌:文献综述
Adv Clin Exp Med. 2018 May;27(5):725-730. doi: 10.17219/acem/68631.
6
The biology and management of non-small cell lung cancer.非小细胞肺癌的生物学特性与治疗管理。
Nature. 2018 Jan 24;553(7689):446-454. doi: 10.1038/nature25183.
7
Targeting RNA helicases in cancer: The translation trap.靶向癌症中的 RNA 解旋酶:翻译陷阱。
Biochim Biophys Acta Rev Cancer. 2017 Dec;1868(2):510-520. doi: 10.1016/j.bbcan.2017.09.006. Epub 2017 Sep 28.
8
GEPIA: a web server for cancer and normal gene expression profiling and interactive analyses.GEPIA:一个用于癌症和正常基因表达谱分析及交互式分析的网络服务器。
Nucleic Acids Res. 2017 Jul 3;45(W1):W98-W102. doi: 10.1093/nar/gkx247.
9
Lung cancer: current therapies and new targeted treatments.肺癌:当前疗法与新的靶向治疗。
Lancet. 2017 Jan 21;389(10066):299-311. doi: 10.1016/S0140-6736(16)30958-8. Epub 2016 Aug 27.
10
Epigenetic down-regulated DDX10 promotes cell proliferation through Akt/NF-κB pathway in ovarian cancer.表观遗传下调的DDX10通过Akt/NF-κB通路促进卵巢癌细胞增殖。
Biochem Biophys Res Commun. 2016 Jan 22;469(4):1000-5. doi: 10.1016/j.bbrc.2015.12.069. Epub 2015 Dec 20.